BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhou X, Wang Y, Li Q, Ma D, Nie A, Shen X. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1). Biochem Biophys Res Commun 2020;530:47-53. [PMID: 32828314 DOI: 10.1016/j.bbrc.2020.06.120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun E, Liu X, Lu C, Liu K. Long non‑coding RNA TTN‑AS1 regulates the proliferation, invasion and migration of triple‑negative breast cancer by targeting miR‑211‑5p. Mol Med Rep 2021;23:45. [PMID: 33179096 DOI: 10.3892/mmr.2020.11683] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 He T, Yuan C, Zhao C. Long intragenic non-coding RNA p53-induced transcript (LINC-PINT) as a novel prognosis indicator and therapeutic target in cancer. Biomed Pharmacother 2021;143:112127. [PMID: 34474342 DOI: 10.1016/j.biopha.2021.112127] [Reference Citation Analysis]
3 Han X, Liu J, Liu Y, Mou L, Li C. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p. Cancer Manag Res 2021;13:4393-401. [PMID: 34103994 DOI: 10.2147/CMAR.S305547] [Reference Citation Analysis]
4 Zuo F, Zhang Y, Li J, Yang S, Chen X. Long noncoding RNA NR2F1-AS1 plays a carcinogenic role in gastric cancer by recruiting transcriptional factor SPI1 to upregulate ST8SIA1 expression. Bioengineered 2021. [PMID: 34738863 DOI: 10.1080/21655979.2021.2001168] [Reference Citation Analysis]
5 Han Z, Li D, Yang Y, Zhang H, M.a B. LINC-DUBR Suppresses Malignant Progression of Ovarian Cancer by Downregulating miR-107 to Induce SMAC Expression. Journal of Healthcare Engineering 2022;2022:1-7. [DOI: 10.1155/2022/4535655] [Reference Citation Analysis]
6 Ren H, Guo X, Li F, Xia Q, Chen Z, Xing Y. Four Autophagy-Related Long Noncoding RNAs Provide Coexpression and ceRNA Mechanisms in Retinoblastoma through Bioinformatics and Experimental Evidence. ACS Omega 2021;6:33976-84. [PMID: 34926945 DOI: 10.1021/acsomega.1c05259] [Reference Citation Analysis]
7 Jiang H, Zhang Z, Yu Y, Chu HY, Yu S, Yao S, Zhang G, Zhang BT. Drug Discovery of DKK1 Inhibitors. Front Pharmacol 2022;13:847387. [PMID: 35355709 DOI: 10.3389/fphar.2022.847387] [Reference Citation Analysis]
8 Papukashvili D, Rcheulishvili N, Liu C, Xie F, Tyagi D, He Y, Wang PG. Perspectives on miRNAs Targeting DKK1 for Developing Hair Regeneration Therapy. Cells 2021;10:2957. [PMID: 34831180 DOI: 10.3390/cells10112957] [Reference Citation Analysis]